Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Galecto, Inc.

Equities

GLTO

US36322Q1076

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-09 pm EDT 		5-day change 1st Jan Change
0.5056 USD -0.47% Intraday chart for Galecto, Inc. +9.56% -29.78%
Jun. 10 Oppenheimer Adjusts Price Target on Galecto to $9 From $10, Maintains Outperform Rating MT
May. 01 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Galecto, Inc. Announces Executive Changes, Effective October 1, 2023
CI
Galecto, Inc. Appoints Stephanie Oestreich, PhD, MPA as Chief Business Officer
CI
Galecto, Inc. Announces Appointment of Garrett Winslow as Senior Vice President, General Counsel
CI
Galecto, Inc. Announces the Appointment of Dr. Anne Prener to Its Board of Directors
CI
Galecto, Inc. Appoints Dr. Jayson Dallas to Board of Directors
CI
Galecto, Inc. Announces Board Changes
CI
Galecto Hires Lindmark as New Chief Medical Officer
CI
Galecto, Inc. Appoints Bertil Lindmark as Chief Medical Officer
CI
Galecto Biotech AB Appoints Richard Marshall as Chief Medical Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. News Galecto, Inc.
  5. Insiders